Point of Care(POC) 임상화학 시장 : 공급업체 점유율, 경쟁 전략, 국가별 부문 예측

Point of Care(POC) 임상화학 시장에 대해 조사 분석했으며, 동향, 역학, 규모, 성장률, 규제 요건, 기술 동향, 경쟁 상황, 장비·소모품 공급업체의 새로운 기회 등의 정보를 전해드립니다.

1. 서론

2. 주요 요약

3. 분산형 검사의 논리적 근거

• 개요
• 규제 동향
• 경제 동향
• 인구통계 동향
• 기술 동향
• 사회 동향
• 의료의 질
• 방어적 의료
• 품질관리(QC)의 문제점

4. 임상화학 검사 리뷰

• 알부민
• 알칼리포스파타아제
• ALT/SGPT
• 암모니아
• 아밀라아제
• AST/SGOT
• 빌리루빈
• 혈액가스
• 혈중요소질소(BUN)
• 칼슘
• 콜레스테롤
• 콜린에스테라아제
• 크레아티닌
• 전해질
• 페리틴
• 폴레이트/엽산
• 후락토사민
• GGT
• 포도당(글루코오스)
• HDL
• 철분
• LDH
• 마그네슘
• 인
• 단백질
• 트리글리세라이드
• 트로포닌
• 요산
• 요검사
• 비타민 B12

5. 장비 : 화학 분석기

6. 현재 및 새로운 기술

• 단일클론항체
• 면역측정(Immunoassay)
• 건식화학(Dry Chemistry)
• 바이오센서
• IT와 자동화
• 분자 진단

7. 미국

• 시장 개요
• 진료소/집단 의료
• 보조적 병원 시설
• 암클리닉
• 외래 진료 센터(ACS)
• 수술 센터
• 요양원
• 조산원
• 주요 공급업체의 판매액과 시장 점유율

8. 주요 제품 개발 기회

9. 분산형 검사 제품의 설계 기준

10. 대체적인 시장 침투 전략

• 내부 개발
• 협력 협정
• 대학과의 계약
• 분산형 검사 시장의 유통 전략

11. 잠재적인 시장 진출 장벽과 위험

• 시장 성숙
• 비용 억제
• 경쟁
• 기술 면에서의 우위성과 한계
• 특허권 보호
• 규제상 제약
• 분산형 검사 시장이 해결해야 할 과제

12. 기업 개요

• Abbott Laboratories
• AdnaGen/Alere
• Agilent Technologies
• Bayer Healthcare
• Beckman Coulter/Danaher
• Biomedical Diagnostics
• BioMerieux
• Bio-Rad
• DiaSorin
• Eiken
• Fujirebio
• Grifols
• Instrumentation Laboratory
• Kyowa Medex
• Matritech/Alere
• Ortho-Clinical Diagnostics
• Quest Diagnostics
• Roche
• Siemens
• Sysmex
• Thermo Fisher
• Tosoh
• Wako
• Wallac/PE

This new 373-page report from VPGMarketResearch.com contains 61 tables, and provides a comprehensive analysis of the POC clinical chemistry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC clinical chemistry market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
 
Market Segmentation Analysis

- Review of nine POC market segments, including their dynamics, trends, structure,
  size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for clinical chemistry procedures
  by market segment:

- Physician Offices/Group Practices    
- Emergency Rooms       
- Operating/Recovery Suites      
- ICUs/CCUs 
- Cancer Clinics        
- Ambulatory Care Centers        
- Surgery Centers 
- Nursing Homes
- Birth Centers

Sales and Market Share Analysis

- Sales and market shares of major clinical chemistry reagent and instrument suppliers.

Current and Emerging Products

- Analysis of clinical chemistry procedures performed in POC testing locations.
- Review of leading clinical chemistry analyzers, both currently marketed and
  those in development, including their operating characteristics, features and selling prices.

Technology Review

- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing clinical Chemistry
   testing technologies and products, by assay.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants,
  including their sales, product portfolios, marketing tactics, joint ventures,
  and new products in R&D.

Strategic Recommendations

- Specific opportunities for new clinical chemistry instruments and reagent systems
   with potentially significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.

Methodology

This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

Contains 373 pages and 61 tables

Table of Contents

Introduction

Executive Summary

Rationale for Testing Decentralization

• 1. Overview
• 2. Regulatory Trends
• 3. Economic Trends
• 4. Demographic Trends
• 5. Technological Trends
• 6. Social Trends
• 7. Quality of Care
• 8. Defensive Medicine
• 9. Quality Control Issues

Review of Clinical Chemistry Tests

• 1. Albumin
• 2. Alkaline Phosphatase
• 3. ALT/SGPT
• 4. Ammonia
• 5. Amylase
• 6. AST/SGOT
• 7. Bilirubin
• 8. Blood Gases
• 9. Blood Urea Nitrogen (BUN)
• 10. Calcium
• 11. Cholesterol
• 12. Cholinesterase
• 13. Creatinine
• 14. Electrolytes
  • a. Carbon Dioxide/Bicarbonate
  • b. Chloride
  • c. Potassium
  • d. Sodium
• 15. Ferritin
• 16. Follate/Folic Acid
• 17. Fructosamine
• 18. Gamma-Glutamyl Transpeptidase (GGT)
• 19. Glucose
• 20. High Density Lipoprotein (HDL)
• 21. Iron
• 22. Lactate Dehydrogenase (LDH)
• 23. Magnesium
• 24. Phosphorus
• 25. Protein
• 26. Triglycerides
• 27. Troponin
• 28. Uric Acid
• 29. Urinalysis
• 30. Vitamin B12

Instrumentation: Chemistry Analyzers Manufactured by:

• Abaxis
• Abbott
• Alfa Wassermann
• Awareness Technologies
• Beckman Coulter/Danaher
• bioMeriuex
• Carolina Chemistries
• Horiba
• Inverness
• Medica
• Nova Biomedical
• Ortho-Clinical Diagnostics
• Polimedco
• Randox
• Roche

Current and Emerging Technologies

• 1. Monoclonal Antibodies
• 2. Immunoassays
  • a. Technological Principle
  • b. Enzyme Immunoassays (EIA)
    • Overview
    • ELISA
    • Dot Immunobinding Assays
    • Capillary Immunoassays
    • Particle-Membrane Capture Immunoassay
    • Enzyme Amplification
  • c. Fluorescent Immunoassays
    • Fluorescent Polarization
    • Time-Resolved Pulse Fluorescence
  • d. Luminescence
    • Chemiluminescence
    • Bioluminescence
  • e. Latex Agglutination
  • f. Immunoprecipitation
• 3. Dry Chemistry
• 4. Biosensors
• 5. IT and Automation
• 6. Molecular Diagnostics
  • a. Technology Overview
  • b. Amplification Methods
    • Polymerase Chain Reaction
    • Ligase Chain Reaction
    • Branched DNA
    • Q-Beta Replicase
    • Strand Displacement Activation
    • Self-Sustained Sequence Replicase

U.S.A.

• A. Market Overview
  • 1. Business Environment
    • a. Health Care Expenditures
    • b. Cost Consciousness
    • c. Reimbursement
    • d. Industry Consolidation
    • e. Managed Care
      • PPO
      • HMO
    • f. Hospitals
    • g. Admissions
    • h. Length of Stay
    • i. Industry Diversification
    • j. Physician Demographics
    • k. Aging Population
      • More Chronic Illness
      • Disease Incidence
      • Susceptibility to latrogenesis
      • Multiple Illnesses Cases
    • l. Laboratory Regulations
  • 2. Market Structure
    • a. Hospitals
    • b. Commercial/Private Laboratories

• B. Physician Offices/Group Practices
  • 1. Market Summary
  • 2. Market Structure
  • 3. Test Volume and Sales Forecasts

• C. Ancillary Hospital Locations
  • 1. Introduction
    • a. Emergency Departments
    • b. Operating Suites
    • c. Intensive Care Units
  • 2. Emergency Departments
    • a. Market Summary
    • b. Test volume and Sales Forecasts
  • 3. Operating and Recovery Suites
    • a. Market Summary
    • b. Test Volume and Sales Forecasts
  • 4. ICUs/CCUs
    • a. Market Summary
    • b. Test Volume and Sales Forecasts

• D. Cancer Clinics
  • 1. Introduction
  • 2. Market Summary
  • 3. Test Volume and Sales Forecasts

• E. Ambulatory Care Centers
  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

• F. Surgery Centers
  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

• G. Nursing Homes
  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

• H. Birth Centers
  • 1. Introduction
  • 2. Market Summary
  • 3. Market Structure
  • 4. Test Volume and Sales Forecasts

• I. Major Suppliers' Sales and Market Shares

Major Product Development Opportunities

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

• A. Internal Development
• B. Collaborative Arrangements
• C. University Contracts
• D. Distribution Strategies for Decentralized Testing Markets
  • 1. Marketing Approaches
  • 2. Product complexity
  • 3. Customer Preference
  • 4. Established Suppliers
  • 5. Emerging Suppliers
  • 6. Major Types of Distributors
  • 7. Market Segmentation

Potential Market Entry Barriers and Risks

• A. Market Maturity
• B. Cost Containment
• C. Competition
• D. Technological Edge and Limitations
• E. Patent Protection
• F. Regulatory Constraints
• G. Decentralized Testing Market Challenges

Company Profile

• Abbott Laboratories
• AdnaGen/Alere
• Agilent Technologies
• Bayer Healthcare
• Beckman Coulter/Danaher
• Biomedical Diagnostics
• BioMerieux
• Bio-Rad
• DiaSorin
• Eiken
• Fujirebio
• Grifols
• Instrumentation Laboratory
• Kyowa Medex
• Matritech/Alere
• Ortho-Clinical Diagnostics
• Quest Diagnostics
• Roche
• Siemens
• Sysmex
• Thermo Fisher
• Tosoh
• Wako
• Wallac/PE

List of Tables

• Major Companies Developing or Marketing Albumin Tests
• Major Companies Developing or Marketing Alkaline Phosphatase Tests
• Major Companies Developing or Marketing ALT/SGPT Tests
• Major Companies Developing or Marketing Amylase Tests
• Major Companies Developing or Marketing AST/SGOT Tests
• Major Companies Developing or Marketing Bilirubin Tests
• Major Companies Developing or Marketing Blood Gas Analyzers
• Major Companies Developing or Marketing BUN Tests
• Major Companies Developing or Marketing Calcium Tests
• Major Companies Developing or Marketing Cholesterol Tests
• Major Companies Developing or Marketing Creatinine Tests
• Major Companies Developing or Marketing Electrolyte Tests
• Major Companies Developing or Marketing Ferritin Tests
• Major Companies Developing or Marketing GGT Tests
• Major Companies Developing or Marketing Glucose Tests
• Major Companies Developing or Marketing HDL Tests
• Major Companies Developing or Marketing Iron Tests
• Major Companies Developing or Marketing LDH Tests
• Major Companies Developing or Marketing Magnesium Tests
• Major Companies Developing or Marketing Phosphorus Tests
• Major Companies Developing or Marketing Protein Tests
• Major Companies Developing or Marketing Triglycerides Tests
• Major Companies Developing or Marketing Uric Acid Tests
• Major Companies Developing or Marketing Vitamin B-12/Folate Tests

• U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
• U.S.A., Physician Offices/Group Practices Forecast by Type
• U.S.A., Office-Based Physicians Forecast by Practice Type
• U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast
• U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast by Practice Type
• U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Reagent Market Forecast By Test
• U.S.A., Ancillary Hospital Locations Estimated Number
• U.S.A., Ancillary Hospital Locations Annual Utilization
• U.S.A., Hospital Emergency Departments Routine And Special Chemistry Test Volume Forecast
• U.S.A., Hospital Emergency Departments Profiles, Panels and Individual Tests
• U.S.A., Hospital Emergency Departments Routine and Special Chemistry Reagent Market Forecast by Test
• U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Test Volume Forecast
• U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Market Forecast by Test
• U.S.A., Hospital ICUs/CCUs Routine And Special Chemistry Test Volume Forecast
• U.S.A., Hospital ICUs/CCUs Routine And Special Reagent Market Forecast by Test
• U.S.A., Cancer Clinics Routine And Special Chemistry Test Volume Forecast
• U.S.A., Cancer Clinics Routine and Special Chemistry Reagent Market Forecast by Test
• U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
• U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
• U.S.A., Ambulatory Care Centers Routine And Special Chemistry Test Volume Forecast
• U.S.A., Ambulatory Care Centers Routine And Special Chemistry Reagent Market Forecast by Test
• U.S.A., Surgery Centers Most Frequently Performed Procedures
• U.S.A., Surgery Centers Routine And Special Chemistry Test Volume Forecast
• U.S.A., Surgery Centers Routine And Special Chemistry Reagent Market Forecast by Test
• U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
• U.S.A., Nursing Homes Routine And Special Chemistry Test Volume Forecast
• U.S.A., Nursing Homes Routine And Special Chemistry Reagent Market Forecast by Test
• U.S.A., Birth Centers Facilities, Patient Visits, and Births
• U.S.A., Birth Centers Routine And Special Chemistry Test Volume Forecast
• U.S.A., Birth Centers Profiles, Panels and Individual Tests
• U.S.A., Birth Centers Routine And Special Chemistry Reagent Market Forecast by Test
• U.S.A., Major Suppliers of Clinical Chemistry Diagnostic Products Estimated Market Shares
• U.S.A., Major Suppliers of Clinical Chemistry Reagents, Estimated Market Shares
• U.S.A., Major Suppliers of Clinical Chemistry Analyzers, Estimated Market Shares
• U.S.A., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
• U.S.A., Major Suppliers of Immunoassay Reagents, Estimated Market Shares
• U.S.A., Major Suppliers of Immunoassay Analyzers, Estimated Market Shares